secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2022-03-18T23:59:59+00:00
Accession:  0001607062-22-000196
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma increases authorized common shares to 5.8B; amends preferred share classes
--------------------------------------------------------------------------------

- Authorized common shares increased from 4.8B to 5.8B, par value $0.0001.
- Series A Preferred authorized set at 540M shares; Series M Preferred at 60M shares.
- Total authorized capital includes 5.8B common, 540M Series A preferred, 60M Series M preferred.
- Amendment effective March 17, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706222000196/0001607062-22-000196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706222000196/rgbp031822form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-22-000196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer